Related Experiment Video
Updated: May 22, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Risk stratification and timing of revascularization: which patients benefit from early versus later
Ian J Sarembock1, Dean J Kereiakes
1The Christ Hospital Heart and Vascular Center and The Lindner Research Center at The Christ Hospital, 2123 Auburn Avenue, Cincinnati, OH 45219, USA. sarembock@ohioheart.org
Insights
Risk stratification for acute coronary syndromes without ST elevation uses clinical, ECG, and biological markers. Guidelines recommend early invasive treatment for high-risk NSTEACS patients.
Area of Science:
- Cardiology
- Internal Medicine
- Emergency Medicine
Background:
- Risk stratification is crucial for acute coronary syndromes (ACS), especially non-ST-elevation ACS (NSTEACS).
- Accurate risk assessment guides treatment decisions and improves patient outcomes.
- Current stratification relies on clinical, electrocardiogram (ECG), and biological markers.
Purpose of the Study:
- To review risk stratification markers and therapeutic strategies for NSTEACS.
- To highlight the importance of early invasive treatment for high-risk NSTEACS patients.
Main Methods:
- Review of clinical, ECG, and biological markers for NSTEACS risk stratification.
- Analysis of established risk scores like TIMI and GRACE.
- Evaluation of therapeutic strategies: routine invasive vs. conservative/selective invasive.
Main Results:
- Key predictors of adverse outcomes in NSTEACS include recent angina, ST-segment deviation on ECG, elevated troponin, myocardial dysfunction markers (BNP, NT-proBNP), and inflammation markers (hs-CRP).
- TIMI and GRACE scores are widely used for risk prediction.
- An early invasive strategy (8-24 hours) is recommended for intermediate to high-risk NSTEACS patients.
Conclusions:
- Effective risk stratification in NSTEACS is essential for guiding timely and appropriate treatment.
- Current guidelines advocate for an early invasive approach in higher-risk NSTEACS populations.
- Integrating multiple markers into risk scores improves prognostic accuracy and treatment selection.
Abstract:
In acute coronary syndromes, risk stratification is essential, particularly in patients without ST elevation, and is based upon clinical, electrocardiogram (ECG), and biological markers. Among them, recent and repeated attacks of angina, ST-segment deviation from baseline on the admission ECG as well as elevated markers of myonecrosis (particularly increased troponin levels), myocardial dysfunction (B-type natriuretic peptide [BNP]; N-terminal prohormone of BNP[NT-proBNP]), and inflammation (high-sensitivity C-reactive protein) are predictors of an adverse outcome. These variables can be incorporated into broader risk predictive scores, among which the TIMI (Thrombolysis in Myocardial Infarction) and GRACE (Global Registry of Acute Coronary Events) scores are the most widely used. Two general therapeutic strategies (routine invasive vs conservative or selective invasive) are employed in the treatment of non-ST-segment elevation acute coronary syndrome (NSTEACS). Evidence-based analysis and the current American College of Cardiology/American Heart Association/Society for Cardiac Angiography and Interventions clinical practice guidelines recommend an early invasive treatment strategy (8-24 h) for intermediate or high clinical risk patients with NSTEACS.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
